Alignment reached on chemistry, manufacturing, and control (CMC) elements of ATH434 Phase 3 development program – – Positive feedback supports ...
Multiple system atrophy (MSA) is an adult-onset, rapidly progressive neurodegenerative disorder characterised by the aggregation of α-synuclein in oligodendroglial cytoplasmatic inclusions.1 ...
Alignment reached on chemistry, manufacturing, and control (CMC) elements of ATH434 Phase 3 development program - - Positive feedback supports readiness for Phase 3 initiation with manufacturing ...
1d
Alterity Therapeutics Releases Appendix 4C – Q3 FY26 Quarterly Cash Flow Report & Corporate Update
Highlights Aligned with the FDA in two Positive Type C meetings supporting key elements of the planned Phase 3 program for ATH434 in MSAAdvancing ...
Alignment reached on chemistry, manufacturing, and control (CMC) elements of ATH434 Phase 3 development program – – Positive feedback supports readiness for Phase 3 initiation with manufacturing scale ...
New NIHR Translational Research Collaboration launched in Parkinson's disease: United Kingdom Monday, April 27, 2026, 12:00 Hrs [IST] The NIHR is expanding its Translational Resea ...
Pomerantz LLP is investigating claims on behalf of investors of Theravance Biopharma, Inc. ("Theravance" or the "Company") . Such investors are advised to contact Danielle Peyton at newaction@pomlaw.
The Parkinson’s disease Translational Research Collaboration (PD-TRC), funded by the National Institute for Health and Care ...
The S&P/ASX 200 has slid on Monday as Iran-US talks stall and push oil futures. Meanwhile buoyant Chinese lithium prices ...
Investing.com -- BioArctic shares fell about 5% on Tuesday after Goldman Sachs cut the stock to "neutral" from "buy," saying ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results